SCHEMBL18318673

SCHEMBL18318673

Cc1nccc2cc(-c3ccc(OC4CCNCC4)cc3)ccc12

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK1 Q13464 6/20 0.59
IKBKB O14920 1/20 0.47
KHK P50053 1/20 0.47
ROCK2 O75116 2/20 0.45
PRKACA P17612 1/20 0.45
PRKCD Q05655 1/20 0.45
PRKG1 Q13976 1/20 0.45
PKN1 Q16512 1/20 0.45
PKN2 Q16513 1/20 0.45
AAK1 Q2M2I8 1/20 0.45
CDC42BPA Q5VT25 1/20 0.45
Q6ZSR9 Q6ZSR9 1/20 0.45
BMP2K Q9NSY1 1/20 0.45
CDC42BPB Q9Y5S2 1/20 0.45
KCNH2 Q12809 2/20 0.44
ACVR1B P36896 1/20 0.43
TGFBR1 P36897 1/20 0.43
ACVR1 Q04771 1/20 0.43
PRKCZ Q05513 2/20 0.43
HRH3 Q9Y5N1 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18318377 0.86 ROCK1 (0.57) ROCK1IKBKBKHKROCK2PRKACA
SCHEMBL18322857 0.85 ROCK1 (0.81) ROCK1IKBKBKHKROCK2PRKACA
SCHEMBL18318650 0.85 ROCK1 (0.59) ROCK1IKBKBKHKROCK2PRKACA
SCHEMBL18318971 0.85 ROCK1 (0.56) ROCK1IKBKBKHKROCK2PRKACA
SCHEMBL18318699 0.85 KHK (0.57) ROCK1IKBKBKHKROCK2PRKACA
SCHEMBL18319500 0.85 ROCK1 (0.56) ROCK1IKBKBKHKROCK2PRKACA
SCHEMBL18318948 0.84 ROCK1 (0.58) ROCK1IKBKBKHKROCK2PRKACA
SCHEMBL18322849 0.81 HRH3 (0.48) ROCK1KHKROCK2KCNH2HRH3
SCHEMBL18318897 0.81 KHK (0.47) ROCK1IKBKBKHKROCK2PRKACA
SCHEMBL18322832 0.80 ROCK1 (0.45) ROCK1KCNH2HRH3HRH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250257035-A1 1,4-Substituted Piperidine Derivatives CEPHALON LLC 2025-08-14 US disclosed
US-12098130-B2 1,4-substituted piperidine derivatives 89BIO LTD (IL) 2024-09-24 US disclosed
US-20230391723-A1 1,4-Substituted Piperidine Derivatives CEPHALON LLC 2023-12-07 US disclosed
US-11702388-B2 1,4-substituted piperidine derivatives 89BIO LTD (IL) 2023-07-18 US disclosed
US-20210230116-A1 1,4-Substituted Piperidine Derivatives CEPHALON LLC 2021-07-29 US disclosed
CN-107847765-B 1, 4-substituted piperidine derivatives 89生物有限公司 2021-05-04 CN disclosed
US-10851057-B2 1,4-substituted piperidine derivatives 89BIO LTD (IL) 2020-12-01 US disclosed
EP-3310441-B1 1, 4-SUBSTITUTED PIPERIDINE DERIVATIVES 89BIO LTD (IL) 2020-07-29 EP disclosed
US-20190152913-A1 1,4-SUBSTITUTED PIPERIDINE DERIVATIVES CEPHALON LLC 2019-05-23 US disclosed
US-10221135-B2 1,4-substituted piperidine derivatives 89BIO LTD (IL) 2019-03-05 US disclosed
US-20180179159-A1 1,4-SUBSTITUTED PIPERIDINE DERIVATIVES CEPHALON LLC 2018-06-28 US disclosed
EP-3310441-A1 1, 4-SUBSTITUTED PIPERIDINE DERIVATIVES Cephalon, Inc. (US) 2018-04-25 EP disclosed
US-9902696-B2 1,4-substituted piperidine derivatives CEPHALON, INC. (US) 2018-02-27 US disclosed
US-20160368874-A1 1,4-SUBSTITUTED PIPERIDINE DERIVATIVES CEPHALON LLC 2016-12-22 US disclosed
WO-2016205633-A1 1, 4-SUBSTITUTED PIPERIDINE DERIVATIVES CEPHALON, INC. (US) 2016-12-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250257035-A1 1,4-Substituted Piperidine Derivatives FASN, CES1, CPT1A ROCK1 2370/4885IKBKB 1701/4885KHK 962/4885
US-20190152913-A1 1,4-SUBSTITUTED PIPERIDINE DERIVATIVES FASN, CES1, CPT1A ROCK1 2370/4885IKBKB 1701/4885KHK 962/4885
US-20230391723-A1 1,4-Substituted Piperidine Derivatives FASN, CES1, CPT1A ROCK1 2370/4885IKBKB 1701/4885KHK 962/4885
US-20160368874-A1 1,4-SUBSTITUTED PIPERIDINE DERIVATIVES FASN, CES1, CPT1A ROCK1 2370/4885IKBKB 1701/4885KHK 962/4885
US-20210230116-A1 1,4-Substituted Piperidine Derivatives FASN, CES1, CPT1A ROCK1 2370/4885IKBKB 1701/4885KHK 962/4885
US-10221135-B2 1,4-substituted piperidine derivatives FASN, CES1, CPT1A ROCK1 2370/4885IKBKB 1701/4885KHK 962/4885
US-11702388-B2 1,4-substituted piperidine derivatives FASN, CES1, CPT1A ROCK1 2370/4885IKBKB 1701/4885KHK 962/4885
US-12098130-B2 1,4-substituted piperidine derivatives FASN, CES1, CPT1A ROCK1 2370/4885IKBKB 1701/4885KHK 962/4885
US-10851057-B2 1,4-substituted piperidine derivatives FASN, CES1, CPT1A ROCK1 2370/4885IKBKB 1701/4885KHK 962/4885
US-20180179159-A1 1,4-SUBSTITUTED PIPERIDINE DERIVATIVES FASN, CES1, CPT1A ROCK1 2507/4885IKBKB 1545/4885KHK 924/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.